IRIS
PELLEGRINO, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.828
AS - Asia 1.571
EU - Europa 878
SA - Sud America 269
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 4
Totale 4.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.752
SG - Singapore 608
CN - Cina 344
VN - Vietnam 296
BR - Brasile 201
IT - Italia 190
IE - Irlanda 189
HK - Hong Kong 134
SE - Svezia 132
DE - Germania 84
ZA - Sudafrica 70
FR - Francia 67
BD - Bangladesh 48
NL - Olanda 46
GB - Regno Unito 38
CA - Canada 36
AR - Argentina 27
AT - Austria 27
IN - India 22
FI - Finlandia 16
IQ - Iraq 16
RU - Federazione Russa 16
ES - Italia 15
MX - Messico 14
PH - Filippine 13
PL - Polonia 13
TR - Turchia 13
CI - Costa d'Avorio 12
EC - Ecuador 11
BE - Belgio 10
CO - Colombia 10
CZ - Repubblica Ceca 10
JP - Giappone 9
ID - Indonesia 8
PK - Pakistan 8
VE - Venezuela 7
AL - Albania 6
EG - Egitto 6
CL - Cile 5
CR - Costa Rica 5
KR - Corea 5
TN - Tunisia 5
TW - Taiwan 5
UZ - Uzbekistan 5
IL - Israele 4
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
PY - Paraguay 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AU - Australia 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JM - Giamaica 3
LT - Lituania 3
NG - Nigeria 3
A1 - Anonimo 2
DZ - Algeria 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
TH - Thailandia 2
UA - Ucraina 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MW - Malawi 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
Totale 4.662
Salva come PNG Salva come JPEG
Città #
Singapore 346
Ashburn 292
San Jose 202
Dublin 186
Chandler 179
Santa Clara 148
Hong Kong 121
Beijing 101
Ho Chi Minh City 100
Dallas 88
Boardman 71
New York 69
Hanoi 65
Johannesburg 61
Council Bluffs 57
Shanghai 56
Los Angeles 42
Lauterbourg 37
Vienna 24
Ann Arbor 23
São Paulo 23
Bremen 22
Princeton 22
Frankfurt am Main 21
Phoenix 21
Hefei 20
Seattle 20
Des Moines 17
Munich 17
Buffalo 16
Parma 14
Dearborn 13
Abidjan 12
Haiphong 12
Helsinki 12
Milan 12
Toronto 12
Brooklyn 11
Montreal 11
Bologna 10
Da Nang 10
Denver 10
Nuremberg 10
Rome 10
Stockholm 9
Warsaw 9
Ardea 8
Atlanta 8
Baghdad 8
Brussels 8
Columbus 8
Moscow 8
Tokyo 8
Wilmington 8
Olomouc 7
Ravenna 7
Rio de Janeiro 7
Campinas 6
Reggio Emilia 6
Thái Nguyên 6
Tirana 6
Amsterdam 5
Falls Church 5
London 5
Modena 5
Poplar 5
Rio Saliceto 5
Belo Horizonte 4
Biên Hòa 4
Brasília 4
Cascina 4
Charlotte 4
City of London 4
Fairfield 4
Ha Long 4
Houston 4
Istanbul 4
Jakarta 4
Kunming 4
Madrid 4
Manchester 4
Mexico City 4
Nanjing 4
Orem 4
Pavia 4
Shenzhen 4
Tashkent 4
The Dalles 4
Turku 4
Verona 4
Vũng Tàu 4
Alessandria 3
Ankara 3
Bexley 3
Boston 3
Buenos Aires 3
Calamba 3
Can Tho 3
Cape Town 3
Caracas 3
Totale 2.906
Salva come PNG Salva come JPEG
Nome #
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy 192
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature 167
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 165
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 163
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 161
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 160
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression 155
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 155
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 155
Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient 145
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 145
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 145
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 140
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 140
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 136
A review of immune checkpoint blockade in breast cancer 132
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review 128
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 126
My best choice after a round trip from illness 125
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 120
A narrative review of the principal glucocorticoids employed in cancer 118
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 115
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 114
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 113
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 111
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 107
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 106
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 103
Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients 100
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review 98
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification 97
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors 92
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review 87
PARP inhibition increases immune infiltration in homologous recombination repair (HRR)-deficient tumors 83
The Innate Immune Microenvironment in Metastatic Breast Cancer 80
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 74
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 66
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 62
Pre-clinical and clinical validation of RAD51 as a functional and dynamic biomaker of DNA repair deficiency by Y homologous recombination 44
Totale 4.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202287 0 0 0 7 5 6 7 5 2 8 0 47
2022/2023652 49 66 33 48 70 71 4 47 214 4 38 8
2023/2024335 13 29 6 4 26 74 34 41 13 28 29 38
2024/2025955 36 40 59 52 113 98 53 42 122 87 73 180
2025/20262.216 220 188 258 213 269 133 207 76 318 190 81 63
2026/2027279 51 117 108 3 0 0 0 0 0 0 0 0
Totale 4.725